Segment And Geographic Information (Tables)

12 Months Ended

Dec. 31, 2013

Segment And Geographic Information [Abstract]

Revenues, Cost Of Services And Products, And Gross Margins For Operating Segments

	2013		2012		2011
Revenues:
Medical devices	$	76,194	$	67,496	$	59,387
Preservation services		64,498		63,603		59,793
Othera		71		619		446
Total revenues		140,763		131,718		119,626
Cost of products and preservation services:
Medical devices		15,147		11,380		9,442
Preservation services		35,230		35,320		34,340
Total cost of products and preservation services		50,377		46,700		43,782
Gross margin:
Medical devices		61,047		56,116		49,945
Preservation services		29,268		28,283		25,453
Othera		71		619		446
Total gross margin	$	90,386	$	85,018	$	75,844

Summary Of Net Revenues By Product

	2013		2012		2011
Products:
BioGlue and BioFoam	$	58,004	$	53,211	$	49,455
PerClot		3,494		3,078		2,528
HemoStase		--		--		1,699
Revascularization technologies		8,965		8,092		5,705
HeRO Graft		5,731		3,115		--
Total products		76,194		67,496		59,387
Preservation services:
Cardiac tissue		29,523		29,756		26,618
Vascular tissue		34,975		33,847		33,175
Total preservation services		64,498		63,603		59,793
Othera		71		619		446
Total revenues	$	140,763	$	131,718	$	119,626

aFor the years ended December 31, 2013,  2012, and 2011 the “Other” designation includes grant revenue.

Schedule Of Net Revenues By Geographic Location

	2013		2012		2011
U.S.	$	109,325	$	103,804	$	95,975
International		31,438		27,914		23,651
Total revenues	$	140,763	$	131,718	$	119,626